Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Combination therapy is more effective for prostate volumes over 60 ml.

Finasteride can cause melasma, especially in people with darker skin.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Ephrin-A3 helps increase and speed up hair growth in baby mice.

5-aminosalicylic acid enemas may cause hair loss.

New compounds may help treat prostate issues without affecting androgen receptors.

Taking Dutasteride with Ketoconazole can increase Dutasteride's effects and side effects.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Baricitinib is an effective treatment for severe alopecia areata.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.